Orgenesis Inc. Share Based Compensation of Revenue

Share Based Compensation of Revenue of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending September 29, 2021 was 3.38% (a 10.1% increase compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue decreased by -83.59%
  • Annual Share Based Compensation of Revenue for 2020 was 258.61% (a 76.96% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2019 was 146.14% (a 434.72% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2018 was 27.33% (a 16.84% increase from previous year)
  • Twelve month Share Based Compensation of Revenue ending September 29, 2021 was 5.35% (a -33.62% decrease compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue decreased by -97.93% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
5.35% 8.06% 128.52% 258.61%
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of Orgenesis Inc.

Most recent Share Based Compensation of Revenueof ORGS including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of Orgenesis Inc.

Orgenesis Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 3.38% 3.07% 6.01%
2020 20.6% 33.02% 1022.24% 46.11% 258.61%
2019 56.49% 37.5% 78.78% 886.4% 146.14%
2018 18.06% 30.32% 19.64% 39.61% 27.33%
2017 4.29% 88.25% 36.66% 0.0%
2016 0.0% 23.15% 146.38% 0.0% 0.0%
2015 27.0%
2014 0.0%
2013 0.0%

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.